GLP-1R信号的结构药理和机制
Qingtong Zhou1, Fenghui Zhao2, Yao Zhang3
1Research Center for Medicinal Structural Biology, National Research Center for Translational Medicine at Shanghai, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; Research Center for Deepsea Bioresources, Sanya, Hainan 572025, China.
结构研究揭示了2型糖尿病和肥胖症的药物如何激活葡萄糖类-1受体 (GLP-1R). 了解这些机制可以改善GLP-1R疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 内分泌学 在内分泌学.
背景情况:
- 葡萄糖类-1受体 (GLP-1R) 是葡萄糖平衡的一个关键调节器.
- GLP-1R是一种B1类G蛋白结合受体.
- GLP-1R信号的失调与2型糖尿病和肥胖有关.
研究的目的:
- 阐明由内源性配体和治疗性激动剂激活GLP-1R的基础结构机制.
- 探索全调节剂在GLP-1R向治疗中的潜力.
- 确定未来的研究方向,以优化基于GLP-1R的治疗方法.
主要方法:
- 低温电子显微镜 (cryo-EM) 是一种低温电子显微镜.
- 在X射线晶体学.
- 质谱测量质量谱测量
- 功能性测试是指功能性测试.
主要成果:
- 详细的结构洞察力GLP-1R激活由激素和激动剂,如semaglutide和tirzepatide.
- 在激活时识别细胞外和膜外域的显著构造变化.
- 新兴的结构数据支持全调节剂的治疗潜力.
结论:
- 结构性药理学提供了对GLP-1R激活的机制理解.
- 赛马格卢提德和蒂尔泽帕提德证明了针对代谢障碍的GLP-1R的治疗疗效.
- 未来的研究应该专注于效应因子相互作用,偏差信号和个性化疗法,以增强GLP-1R药物开发.
更多相关视频
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
12:27A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G-protein Coupled Receptors
GPCRs Regulate Adenylyl Cylase Activity
Amplifying Signals via Enzymatic Cascade
